Bausch Health
BHC
#4631
Rank
A$3.45 B
Marketcap
A$9.24
Share price
-1.41%
Change (1 day)
-17.75%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): A-$4.63

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A-$4.51. In 2025 the company made an earnings per share (EPS) of A$0.58 an increase over its 2024 EPS that were of A-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.63-892.55%
2025A$0.58-450%
2024A-$0.17-92.59%
2023A-$2.26160.89%
2022A-$0.86-76.64%
2021A-$3.7068.45%
2020A-$2.20-68.91%
2019A-$7.06-57.11%
2018A-$16.47-272.22%
2017A$9.56-199.29%
2016A-$9.63798.7%
2015A-$1.07-128.31%
2014A$3.79-204.62%
2013A-$3.62602.7%
2012A-$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.38-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.32-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA